Restructure Would Give EMA Four New Drug-Support Divisions

Written on:October 8, 2013
Comments are closed

Initial plans for restructuring the European Medicines Agency, released Sept. 16, call for the creation of four new drug oversight divisions and new structures to support the scientific work of the agency’s committees.

Source: International Pharmaceutical Regulatory Monitor


Sorry, the comment form is closed at this time.